Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 57 citing SWEET: Five years' treatment of Parkinson's disease with levodopa: therapeutic results and.... (0.11 sec) 

Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the …


JE Ahlskog, MD Muenter - Movement disorders, 2001 - interscience.wiley.com
We searched MEDLINE for all English language publications reporting the
cumulative frequency of levodopa-induced dyskinesias or motor fluctuations
during discrete intervals of treatment. This generated 2,478 publications ...
Cited by 279 - Related articles - BL Direct - All 5 versions

Epidemiology of parkinsonism


AH Rajput, A Rajput, M Rajput - Handbook of Parkinson's disease, 2003 - books.google.com
Epidemiology of Parkinsonism AM H. Rajput, Alex Rajput, and Michele Rajput
University of Saskatchewan, Saskatoon, Saskatchewan, Canada Epidemiology is the
study of large numbers of individuals to ascertain incidence, life ...
Cited by 240 - Related articles - BL Direct - All 5 versions

Dyskinesias and motor fluctuations in Parkinson's disease: a community-based study

- oxfordjournals.org
A Schrag, N Quinn - Brain, 2000 - Oxford Univ Press
We investigated the prevalence of dyskinesias and motor fluctuations, and the
factors determining their occurrence, in a community-based population of
patients with Parkinson's disease. Among 124 patients with Parkinson's ...
Cited by 189 - Related articles - BL Direct - All 4 versions

Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their …


MG Murer, G Dziewczapolski, LB Menalled, … - Annals of neurology, 1998 - interscience.wiley.com
Orally administered levodopa remains the most effective symptomatic treatment
for Parkinson's disease (PD). The introduction of levodopa therapy is often
delayed, however, because of the fear that it might be toxic for the ...
Cited by 145 - Related articles - BL Direct - All 4 versions

The impact of treatment with levodopa on Parkinson's disease


KM Shaw, AJ Lees, GM Stern - QJM, 1980 - Oxford Univ Press
SUMMARY The progress of 178 patients with Parkinson's disease who began
treatment with levodopa between November 1969 and December 1972 is reviewed
after six years. One hundred and twenty-five patients showed an initial ...
Cited by 107 - Related articles - All 2 versions

Multi-center study of Parkinson mortality with early versus later dopa treatment


SG Diamond, CH Marchkham, MM Hoehn, FH … - Annals of neurology, 1987 - interscience.wiley.com
Four geographically diverse centers provided data on mortality in 359 patients
with Parkinson's disease, the majority of whom began dopa treatment during the
early experimental trials of 1968 to 1970. Patients were classified into ...
Cited by 92 - Related articles - All 4 versions

The association of incident dementia with mortality in PD


G Levy, MX Tang, ED Louis, LJ Cote, B Alfaro, … - Neurology, 2002 - AAN Enterprises
From the Gertrude H. Sergievsky Center (Drs. Levy, Tang, Louis, Stern, and
Marder, and B. Alfaro and H. Mejia), the Department of Neurology (Drs. Louis,
Côté, Stern, and Marder, and B. Alfaro and H. Mejia), and the Department ...
Cited by 77 - Related articles - BL Direct - All 3 versions

Long-term follow-up review of cases of Parkinson's disease after unilateral or bilateral …


K Matsumoto, F Shichijo, T Fukami - Journal of neurosurgery, 1984 - thejns.org
Follow-up reviews were carried out on 86 of 103 patients with Parkinson's
disease who underwent unilateral or bilateral ventrolateral (VL) thalamotomy in
the period from 1964 to 1969. Of these 86 patients, 64 received unilateral ...
Cited by 73 - Related articles - All 4 versions

Motor complications of chronic levodopa therapy in Parkinson's disease


E Miyawaki, K Lyons, R Pahwa, AI Tröster, J … - Clinical neuropharmacology, 1997 - journals.lww.com
Clinical Neuropharmacology Vol. 20, No. 6, pp. 523-530 © 1997 Lippincott-Raven
Publishers, Philadelphia Motor Complications of Chronic Levodopa Therapy in
Parkinson's Disease Edison Miyawaki, Kelly Lyons, Rajesh Pahwa, Alexander ...
Cited by 54 - Related articles - BL Direct - All 4 versions

Risk factors for levodopa-induced dyskinesias in Parkinson's disease


F Grandas, ML Galiano, C Tabernero - Journal of neurology, 1999 - Springer
Levodopa associated with a peripheral dopa decarboxy- lase inhibitor remains the
mainstay of treatment of Parkin- son's disease. However, complications related
to chronic levodopa therapy, especially motor fluctuations and dys- ...
Cited by 47 - Related articles - BL Direct - All 4 versions


Result Page: 

1

2

3

4

5

6

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google